Together, flow cytometry and cell viability experiments further confirm the ability of both PJ-1 and PJ-9 to restore P53 activity and to regulate kinetic expression of the mutant protein, B-Raf in cancer cells with a dynamic effect in normal cells. Here, TP53 is linked to cancer.